| The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features MA Nagel, RJ Cohrs, R Mahalingam, MC Wellish, B Forghani, A Schiller, ... Neurology 70 (11), 853-860, 2008 | 588 | 2008 |
| Virus-induced exacerbations in asthma and COPD D Kurai, T Saraya, H Ishii, H Takizawa Frontiers in microbiology 4, 293, 2013 | 225 | 2013 |
| Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients S Sato, K Masui, N Nishina, Y Kawaguchi, A Kawakami, M Tamura, ... Rheumatology 57 (7), 1212-1221, 2018 | 137 | 2018 |
| Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications T Saraya, D Kurai, K Nakagaki, Y Sasaki, S Niwa, H Tsukagoshi, ... Frontiers in microbiology 5, 410, 2014 | 120 | 2014 |
| Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan H Ishii, R Tazawa, C Kaneko, T Saraya, Y Inoue, E Hamano, Y Kogure, ... European Respiratory Journal 37 (2), 465-468, 2011 | 115 | 2011 |
| Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious … K Yanagihara, J Kadota, N Aoki, T Matsumoto, M Yoshida, M Yagisawa, ... Journal of Infection and Chemotherapy 21 (6), 410-420, 2015 | 83 | 2015 |
| Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis/dermatomyositis–associated interstitial lung disease T Gono, K Masui, N Nishina, Y Kawaguchi, A Kawakami, K Ikeda, Y Kirino, ... Arthritis & Rheumatology 73 (4), 677-686, 2021 | 81 | 2021 |
| Efficacy and safety of favipiravir in moderate COVID-19 pneumonia patients without oxygen therapy: a randomized, phase III clinical trial M Shinkai, K Tsushima, S Tanaka, E Hagiwara, N Tarumoto, I Kawada, ... Infectious diseases and therapy 10 (4), 2489-2509, 2021 | 79 | 2021 |
| Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan H Ishii, JF Seymour, R Tazawa, Y Inoue, N Uchida, A Nishida, Y Kogure, ... BMC pulmonary medicine 14, 1-10, 2014 | 73 | 2014 |
| Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious … A Watanabe, K Yanagihara, T Matsumoto, S Kohno, N Aoki, T Oguri, ... Journal of Infection and Chemotherapy 18 (5), 609-620, 2012 | 71 | 2012 |
| Mycoplasma pneumoniae infection: Basics T Saraya Journal of General and Family Medicine 18 (3), 118-125, 2017 | 68 | 2017 |
| Epidemiology of virus-induced asthma exacerbations: with special reference to the role of human rhinovirus T Saraya, D Kurai, H Ishii, A Ito, Y Sasaki, S Niwa, N Kiyota, H Tsukagoshi, ... Frontiers in microbiology 5, 226, 2014 | 67 | 2014 |
| IL-17A synergistically stimulates TNF-α-induced IL-8 production in human airway epithelial cells: a potential role in amplifying airway inflammation K Honda, H Wada, M Nakamura, K Nakamoto, T Inui, M Sada, T Koide, ... Experimental lung research 42 (4), 205-216, 2016 | 65 | 2016 |
| Molecular evolution of the capsid gene in human norovirus genogroup II M Kobayashi, Y Matsushima, T Motoya, N Sakon, N Shigemoto, ... Scientific reports 6 (1), 29400, 2016 | 60 | 2016 |
| Mycoplasma pneumoniae Extract Induces an IL-17-Associated Inflammatory Reaction in Murine Lung: Implication for Mycoplasmal Pneumonia D Kurai, K Nakagaki, H Wada, T Saraya, S Kamiya, Y Fujioka, K Nakata, ... Inflammation 36, 285-293, 2013 | 59 | 2013 |
| The History of Mycoplasma pneumoniae Pneumonia T Saraya Frontiers in microbiology 7, 364, 2016 | 58 | 2016 |
| Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2008: general view of the pathogens’ antibacterial susceptibility Y Niki, H Hanaki, T Matsumoto, M Yagisawa, S Kohno, N Aoki, ... Journal of Infection and Chemotherapy 17, 510-523, 2011 | 54 | 2011 |
| A simple method for differentiating complicated parapneumonic effusion/empyema from parapneumonic effusion using the split pleura sign and the amount of pleural effusion on … N Tsujimoto, T Saraya, RW Light, Y Tsukahara, T Koide, D Kurai, H Ishii, ... PLoS One 10 (6), e0130141, 2015 | 53 | 2015 |
| Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times S Takata, H Wada, M Tamura, T Koide, M Higaki, S Mikura, T Yasutake, ... Biomarkers 16 (6), 530-535, 2011 | 52 | 2011 |
| High-resolution CT findings of patients with pulmonary nocardiosis N Tsujimoto, T Saraya, K Kikuchi, S Takata, Y Kurihara, S Hiraoka, ... Journal of Thoracic Disease 4 (6), 577, 2012 | 48 | 2012 |
